Sectoral Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sectoral Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-230,043	Closed	-$21.4M	–	123
2021 Q4	$21.4M	Sell	230,043 -138,356	-38%	-$9.12M	3.22%	1
2021 Q3	$21.9M	Buy	368,399 +45,800	+14%	+$2.71M	1.82%	14
2021 Q2	$22M	Buy	322,599 +940	+0.3%	+$61.3K	1.78%	9
2021 Q1	$22.3M	Buy	321,659 +1,600	+0.5%	+$123K	1.69%	19
2020 Q4	$24.6M	Sell	320,059 -89,846	-22%	-$6.73M	1.73%	24
2020 Q3	$30.7M	Buy	409,905 +47,005	+13%	+$3.13M	2.64%	5
2020 Q2	$22.8M	Buy	+362,900	New	+$20M	2.1%	7
2018 Q4	–	Sell	-7,208	Closed	-$332K	–	151
2018 Q3	$332K	Buy	+7,208	New	+$292K	0.04%	103

Sectoral Asset Management's ARNA Position: Q1 2022 in Review

Sectoral Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 230,043 shares — an estimated $21.4M sold.

Sectoral Asset Management first reported a position in ARNA in Q3 2018 and held it in 8 quarters. The position peaked at $30.7M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Sectoral Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Sectoral Asset Management sold 230,043 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $21.4M.
Sectoral Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 8 quarters.
Sectoral Asset Management's Arena Pharmaceuticals Inc position peaked at $30.7M in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.